CCME Global Limited has announced that its board meeting is scheduled to be held on Friday, May 29, 2026, at Mumbai. The primary agenda of the meeting is to consider and approve the audited financial results for the fourth quarter and the financial year ending on March 31, 2026. This decision is taken pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

The board will also review the audit report accompanying these financial results. The approval process is in line with Regulation 33 of the Listing Obligations and Disclosure Requirements, 2015. Any other business with the permission of the chair may also be taken up during the meeting.

In accordance with the company's Code of Conduct for Prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the company is currently closed. The window closed on Wednesday, April 01, 2026, and will remain shut until 48 hours after the declaration of the audited standalone financial results.

Key Meeting Details

The company has requested the stock exchange to take the information on record and acknowledge the receipt of the same. The intimation was signed by Poonam Chaturvedi, Managing Director of CCME Global Limited.

CCME Global Limited (formerly known as Genesis IBRC India Limited) has received listing approval from BSE Limited for a significant equity share issuance on preferential basis. The company announced this development on April 30, 2026, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Share Issuance Details

The BSE approval covers the listing of substantial equity shares issued to both promoters and non-promoters on a preferential basis.

BSE Approval and Compliance Requirements

BSE Limited granted the listing approval on April 29, 2026, through its letter reference LOD/PREF/DA/FIP/150/2026-27. The exchange has specified several compliance requirements that the company must fulfill.

Key compliance obligations include:

• Adherence to Regulation 167 of SEBI (ICDR) Regulations
• Filing shareholding pattern in XBRL mode if changes exceed two percent of total paid-up share capital
• Compliance with Regulation 31(1)(c) of SEBI LODR Regulations, 2015

Trading Approval Requirements

BSE has outlined specific conditions that must be met before trading approval is granted for the newly issued shares:

• Listing approval from National Stock Exchange of India Ltd. (if applicable)
• Confirmation letters from NSDL/CDSL regarding crediting shares to beneficiary accounts
• Confirmation of admitting the capital to the depository system
• Lock-in confirmation for pre-preferential holdings (if applicable)

Timeline and Regulatory Compliance

The company must submit an application for trading approval within seven working days from the date of listing approval, as per Schedule XIX of ICDR Regulations and SEBI circular SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023. Non-compliance with this timeline requirement will attract penalties as specified in the regulatory circular.

Company Information

CCME Global Limited operates under CIN L46909AP1992PLC107068 with its registered office located in Eluru, Andhra Pradesh, and corporate office in Mumbai. The announcement was signed by Poonam Chaturvedi, Managing Director (DIN: 05163733), confirming the receipt of BSE's listing approval for the preferential issue.